Teva has announced a new organization and leadership structure to take effect immediately. This news follows an earlier announcement by Teva of staff reductions of 7,000 employees and the closing or divestment of 15 manufacturing plants as well as the appointment of a new president and CEO. The company said it will announce a more detailed restructuring plan in mid-December. Read More

Avantor, a supplier of ultra-high-purity materials for the life sciences and advanced technology industries, has completed its $6.5-billion acquisition of VWR Corporation, a provider of product, supply chain, and service solutions to laboratory and production customers. Read More

The Senate Health, Education, Labor and Pensions Committee held a hearing of President Trump’s nominee for the US Department of Health and Human Services (HHS), Alex Azar, a former executive at Eli Lilly and Company and former HHS Deputy Secretary and General Counsel. Read More

FDA Commissioner Scott Gottlieb has announced FDA plans to address drug shortages resulting from manufacturing disruptions following recent Hurricanes Irma and Maria in Puerto Rico. Read More

The European Medicines Agency (EMA) has issued additional guidance to help pharmaceutical companies prepare for the UK’s withdrawal from the European Union. Read More

Fresenius Kabi, a specialty and generic pharmaceuticals company and a subsidiary of Fresenius KGaA, a healthcare group, plans to invest $100 million to expand its sterile injectable manufacturing operations in Wilson County, North Carolina. Read More

AMRI has more than doubled its bulk active pharmaceutical ingredient (API) aseptic manufacturing capacity by adding a new multipurpose aseptic API line at its facility in Valladolid, Spain. Read More

FDA Commissioner Scott Gottlieb outlined steps the agency is taking to improve the generic-drug review process, including work to finalize draft guidance on complex generic drugs. Read More

The FDA has issued final guidance to assist companies in their development of generic versions of approved opioids with abuse-deterrent formulations. Read More

The European Commission (EC) has issued a set of GMP guidelines for advanced therapy medicinal products, which are medicines for human use that are based on genes or cells. Read More